Journal of veterinary internal medicine
Cure8 research brief
Why This Matters
The study shows that mucosal CD3+ T‑cell density is higher in dogs with an IBD-like condition than in healthy dogs, suggesting mucosal T‑cell infiltration is part of the disease but may not reflect how sick an individual animal is.
That means CD3 counts alone probably won't guide treatment decisions but could aid research into immune subtypes.
Who Should Pay Attention
veterinary clinicians; veterinary researchers studying mucosal immunology or biomarkers; patients/owners of dogs with chronic enteropathies (for contextual interest)
Study Snapshot
Story typeResearch paper
Evidence typeResearch paper
Source depthJournal abstract
What To Know
This was a retrospective multicenter study using archived endoscopic biopsies from duodenum, ileum, and colon and digital image analysis to quantify CD3+ cells.
The authors report significantly higher relative CD3+ density in all three segments in affected dogs, yet CD3+ density did not correlate with clinical indices, serum albumin, or overall histologic scores, so CD3 quantification alone is not a reliable monitoring marker.
The paper suggests CD3 counts may help with immunophenotyping but should not replace clinical or histologic assessment. The report is based on dogs (veterinary patients), not humans; applicability to human IBD is limited.
The study used archived endoscopic biopsies and digital image analysis; results reflect group differences but not individual prognostic utility.
Keep In Mind
Study is in dogs (immunomodulator‑responsive enteropathy) and used archived endoscopic biopsies with digital image analysis. The extracted content is an abstract; full paper review may provide more detail on methods and limitations.
Source Details
Review the original publication for the complete reporting, methods, and context.
Research paper
Evidence type derived from source or registry metadata.
PublicationJournal of veterinary internal medicine
AuthorsBouillet G, Méric T, Gonel G +15 more
Study typeIm, multicenter study, journal article
Indexed viaEurope PMC
Source typeResearch paper
PublishedJul 1, 2026, 12:00 AM
Content availableJournal abstract
Funding disclosed by the source: EuroMed-MIHA
This Cure8 brief is based on source text from the linked article. Cure8 is informational only and is not a substitute for professional medical advice, diagnosis, or treatment.
Crohn's atlas maps gene shifts across more than 50 gut cell types
The atlas maps which genes and cell types are different in Crohn's disease, offering clues about why inflammation persists and pointing to specific immune pathways (like JAK/STAT) that are already drug targets. The...
Bacterial Metatranscriptomics from Human Tissues to Resolve Contributions of Host and Microbial Pathways to Health and Disease
The project aims to enable simultaneous RNA-level profiling of microbes and host cells from human biopsies, which could reveal early microbial and host gene-expression patterns linked to subclinical Crohn’s disease and...
Systematic Review: Evaluating the Prognostic Value of Granulomas in Crohn’s Disease
Granulomas are a classic histologic feature of Crohn’s disease, so patients and clinicians may wonder whether their presence predicts worse disease or different treatment needs. This review shows existing studies are...